Invention Grant
- Patent Title: Use of endocytosis inhibitors and antibodies for cancer therapy
-
Application No.: US14438440Application Date: 2013-10-28
-
Publication No.: US10253107B2Publication Date: 2019-04-09
- Inventor: Fiona Simpson , Nicholas Andrew Saunders
- Applicant: THE UNIVERSITY OF QUEENSLAND
- Applicant Address: AU St. Lucia
- Assignee: THE UNIVERSITY OF QUEENSLAND
- Current Assignee: THE UNIVERSITY OF QUEENSLAND
- Current Assignee Address: AU St. Lucia
- Agency: Nixon & Vanderhye P.C.
- Priority: AU2012904722 20121026
- International Application: PCT/AU2013/001246 WO 20131028
- International Announcement: WO2014/063205 WO 20140501
- Main IPC: A61K31/18
- IPC: A61K31/18 ; A61K31/166 ; A61K31/351 ; A61K31/505 ; A61K31/724 ; A61K31/4706 ; A61K31/5415 ; A61K39/00 ; A61K39/395 ; A61K45/06 ; C07K16/28 ; C07K16/30 ; C07K16/32 ; G01N33/574
Abstract:
The present invention relates to the use of endocytosis inhibitors, including clathrin-dependent endocytosis inhibitors such as inhibitors of dynamin and antibodies, for enhancing the immune response to cancer, and thereby treating cancers including cancer associated receptor positive cancers.
Public/Granted literature
- US20150284469A1 USE OF ENDOCYTOSIS INHIBITORS AND ANTIBODIES FOR CANCER THERAPY Public/Granted day:2015-10-08
Information query
